Found "Vaccines": 74 results
Sort by
Z - A

China Health Technology Assessment (HTA) Hub

The past few years have seen significant progress in the development of Health Technology Assessment (HTA) in China. The China National Health Development Research Center (CNHDRC), the national focal point for HTA in China, has stepped up efforts to roll out HTA activities in many ways in order to s

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

Summary The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccines that protect against severe disease and preferably drive herd immunity. Regulators in numerous countries have authorised or approved COVID-19 vaccines for human use, with more expected to be licensed in 20

Bridging gaps in vaccinology: Enhancing capacity for effective vaccine distribution in Indonesia and other LMICs

The COVID-19 pandemic exposed vulnerabilities within national health systems, including in vaccine delivery and distribution. This has underscored the vital importance of having in place effective vaccination strategies and the need to strengthen national and regional capabilities in the fi

Bird Flu Paper Is Published After Debate

The more controversial of two papers describing how the lethal H5N1 bird flu could be made easier to spread was published Thursday, six months after a scientific advisory board suggested that the papers’ most potentially dangerous data be censored.The paper, by scientists at Erasmus Medical Center i

Bhutan’s oldest newspaper shows appreciation on iDSI’s support to evaluate new vaccines in Bhutan

Bhutan’s national and also the oldest newspaper named ‘Kuensel’ from the Kuensel Corporation Limited published a story featuring, our support to the Bhutanese government in evaluating new vaccines through an economic evaluation, in their issue of 28th August 2017 http://www.kuenselonline.com/moh-exp

Bhutan’s oldest newspaper shows appreciation on iDSI’s support to evaluate new vaccines in Bhutan

Bhutan’s national and also the oldest newspaper named ‘Kuensel’ from the Kuensel Corporation Limited published a story featuring, our support to the Bhutanese government in evaluating new vaccines through an economic evaluation, in their issue of 28th August 2017 http://www.kuenselonline.com/moh-exp

Beyond coverage decisions – Using HTA to link technology supply and population health demand

Policymakers across the world are regularly required to make crucial decisions about resource allocation and prioritize interventions – medicine A or medicine B, subsidize heart surgery or expand the immunization program. This process is required to be transparent, accountable a

Are COVID-19 vaccines with 90% efficacy always better than ones with 70% efficacy?

In the late year of 2020, the COVID-19 vaccines in the news which claim itself for possessing 90% efficacy seems to be the light at the end of the tunnel for all population in the world. All eyes are being kept on the upcoming promising vaccines while ones with lower efficacy are seen scept

An early health technology assessment of target product profiles for COVID-19 vaccines: data for supporting R&D for better vaccine and selecting the right vaccine for maximising public health impact

การระบาดของโรคติดเชื้อไวรัสโคโรนา 2019 (COVID-19) ทำให้มีผู้ติดเชื้อและเสียชีวิตทั่วโลก ทางออกที่ยั่งยืนของวิกฤตครั้งนี้ คือ การมี

Advancing Universal Health Coverage Through Health Technology Assessment (HTA) – A Perspective from Kerala

The 2019 National University of Singapore (NUS) Initiative to Improve Health in Asia Leadership Development Programme (NIHA LDP) was held at NUS, Singapore from the 24th – 29th June. The event aimed to equip policy-makers with an understanding of  health technology assessment (HTA) for health care p
10 / Page